John Slade – författare

Around-the-clock tobacco talks, multibillion-dollar lawsuits against the major cigarette companies, and legislative wrangling over how much to tax a pack of cigarettes--these are some of the most recent episodes in the war against the tobacco companies. The Cigarette Papers shows what started it all: revelations that tobacco companies had long known the grave dangers of smoking, and did nothing about it. In May 1994 a box containing 4,000 pages of internal tobacco industry documents arrived at the office of Professor Stanton Glantz at the University of California, San Francisco. The anonymous source of these "cigarette papers" was identified only as "Mr. Butts." These documents provide a shocking inside account of the activities of one tobacco company, Brown & Williamson, over more than thirty years. Quoting extensively from the documents themselves and analyzing what they reveal, The Cigarette Papers shows what the tobacco companies have known and galvanizes us to take action.

This comprehensive, clinical text on tobacco dependence provides clinicians not only with information on how to diagnose and treat nicotine addicted patients, but also with the medical, epidemiological and behavioral science backgrounds necessary for understanding the process and dynamics of tobacco dependence. The book breaks new ground by defining and explaining nicotine addiction as a primary problem or disease in its own right, instead of as a habit or risk factor for other diseases. It follows the traditional outline of medical texts: Part I covers etiology, pathogenesis and complications; Part II covers diagnosis and treatment; and Part III covers prevention and public health.Part I is designed to present an overview of the biological, psychological, social, and societal factors that contribute to nicotine dependence. Topics include: a description of nicotine delivery systems, psychopharmacology, economics, natural history and epidemiology, mortality, morbidity, and environmental tobacco smoke exposure. Part II provides the clinician with practical guidelines and tools for treating nicotine dependence. The authors describe a stepped-care treatment model, with brief interventions that can be easily integrated into routine medical practice. This section also covers the role of psychopharmacologic and formal treatment programs, the treatment of smokeless toabacco addiction, and treating nicotine dependence in pregnant women and in people with medical illnesses, other chemical dependencies, or psychiatric disorders. The last section, on public health and prevention, focuses on worksite and community intervention programs. It also summarizes the research on smoking patterns and history in women, blacks, hispanics, youth, and older adults, and shows how intervention and prevention programs could be made more effective in these groups. Written by leading experts in this timely field, this imortant work contains information not found elsewhere.